148 related articles for article (PubMed ID: 19500386)
1. Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.
White KL; Vierkant RA; Phelan CM; Fridley BL; Anderson S; Knutson KL; Schildkraut JM; Cunningham JM; Kelemen LE; Pankratz VS; Rider DN; Liebow M; Hartmann LC; Sellers TA; Goode EL
BMC Cancer; 2009 Jun; 9():170. PubMed ID: 19500386
[TBL] [Abstract][Full Text] [Related]
2. IkappaB genetic polymorphisms and invasive pneumococcal disease.
Chapman SJ; Khor CC; Vannberg FO; Frodsham A; Walley A; Maskell NA; Davies CW; Segal S; Moore CE; Gillespie SH; Denny P; Day NP; Crook DW; Davies RJ; Hill AV
Am J Respir Crit Care Med; 2007 Jul; 176(2):181-7. PubMed ID: 17463416
[TBL] [Abstract][Full Text] [Related]
3. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case-control study in Shanghai, China.
Gao J; Xu HL; Gao S; Zhang W; Tan YT; Rothman N; Purdue M; Gao YT; Zheng W; Shu XO; Xiang YB
BMJ Open; 2014 Feb; 4(2):e004427. PubMed ID: 24578542
[TBL] [Abstract][Full Text] [Related]
5. Association between genetic polymorphisms of inflammatory response genes and the risk of ovarian cancer.
Lu ZH; Gu XJ; Shi KZ; Li X; Chen DD; Chen L
J Formos Med Assoc; 2016 Jan; 115(1):31-7. PubMed ID: 25659662
[TBL] [Abstract][Full Text] [Related]
6. Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.
Zhao Z; Zhong X; Wu T; Yang T; Chen G; Xie X; Wei Y; Ye M; Zhou Y; Du Z
Int J Mol Med; 2014 Nov; 34(5):1233-40. PubMed ID: 25215581
[TBL] [Abstract][Full Text] [Related]
7. Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.
Lake A; Shield LA; Cordano P; Chui DT; Osborne J; Crae S; Wilson KS; Tosi S; Knight SJ; Gesk S; Siebert R; Hay RT; Jarrett RF
Int J Cancer; 2009 Sep; 125(6):1334-42. PubMed ID: 19507254
[TBL] [Abstract][Full Text] [Related]
8. Association of NFKB1 and NFKBIA gene polymorphisms with susceptibility of gastric cancer.
Li D; Wu C; Cai Y; Liu B
Tumour Biol; 2017 Jul; 39(7):1010428317717107. PubMed ID: 28670959
[TBL] [Abstract][Full Text] [Related]
9. Common Polymorphisms in the NFKBIA Gene and Cancer Susceptibility: A Meta-Analysis.
Zhang M; Huang J; Tan X; Bai J; Wang H; Ge Y; Xiong H; Shi J; Lu W; Lv Z; Liang C
Med Sci Monit; 2015 Oct; 21():3186-96. PubMed ID: 26488500
[TBL] [Abstract][Full Text] [Related]
10. Haplotypic structure across the I kappa B alpha gene (NFKBIA) and association with multiple myeloma.
Spink CF; Gray LC; Davies FE; Morgan GJ; Bidwell JL
Cancer Lett; 2007 Feb; 246(1-2):92-9. PubMed ID: 16540234
[TBL] [Abstract][Full Text] [Related]
11. Identification of variants in NFKBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patients.
Kim LH; Shin HD; Park BL; Jung JH; Kim JY; Kim YJ; Lee HS
Hum Mutat; 2003 Jun; 21(6):652-3. PubMed ID: 14961554
[TBL] [Abstract][Full Text] [Related]
12. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.
Benusiglio PR; Lesueur F; Luccarini C; McIntosh J; Luben RN; Smith P; Dunning A; Easton DF; Ponder BA; Pharoah PD
BMC Cancer; 2005 Jul; 5():81. PubMed ID: 16029503
[TBL] [Abstract][Full Text] [Related]
13. Expression of classical NF-kappaB pathway effectors in human ovarian carcinoma.
Darb-Esfahani S; Sinn BV; Weichert W; Budczies J; Lehmann A; Noske A; Buckendahl AC; Müller BM; Sehouli J; Koensgen D; Györffy B; Dietel M; Denkert C
Histopathology; 2010 May; 56(6):727-39. PubMed ID: 20546338
[TBL] [Abstract][Full Text] [Related]
14. Lost and Found: The Family of NF-κB Inhibitors Is Larger than Assumed in Salmonid Fish.
van Muilekom DR; Collet B; Rebl H; Zlatina K; Sarais F; Goldammer T; Rebl A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373375
[TBL] [Abstract][Full Text] [Related]
15. Association of the genetic polymorphisms of NFKB1 with susceptibility to ovarian cancer.
Chen LP; Cai PS; Liang HB
Genet Mol Res; 2015 Jul; 14(3):8273-82. PubMed ID: 26345753
[TBL] [Abstract][Full Text] [Related]
16. Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer.
White KL; Rider DN; Kalli KR; Knutson KL; Jarvik GP; Goode EL
Cancer Causes Control; 2011 May; 22(5):785-801. PubMed ID: 21359843
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte enhancer-binding protein-1 promotes macrophage inflammatory responsiveness by up-regulating NF-kappaB via IkappaBalpha negative regulation.
Majdalawieh A; Zhang L; Ro HS
Mol Biol Cell; 2007 Mar; 18(3):930-42. PubMed ID: 17202411
[TBL] [Abstract][Full Text] [Related]
18. IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cells.
Malek S; Chen Y; Huxford T; Ghosh G
J Biol Chem; 2001 Nov; 276(48):45225-35. PubMed ID: 11571291
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer.
Peedicayil A; Vierkant RA; Shridhar V; Schildkraut JM; Armasu S; Hartmann LC; Fridley BL; Cunningham JM; Phelan CM; Sellers TA; Goode EL
Gynecol Oncol; 2009 Aug; 114(2):260-4. PubMed ID: 19419758
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism in NFKBIA gene is associated with recurrent acute rejections in liver transplant recipients.
Kramer K; Thye T; Treszl A; Peine S; Koch M; Sterneck M; Nashan B; Thude H
Tissue Antigens; 2014 Oct; 84(4):370-7. PubMed ID: 25112903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
